|
WO2000050006A2
(en)
|
1999-02-26 |
2000-08-31 |
Chiron Corporation |
Microemulsions with adsorbed macromoelecules and microparticles
|
|
WO2001021810A1
(en)
|
1999-09-17 |
2001-03-29 |
Aventis Pasteur Limited |
Chlamydia antigens and corresponding dna fragments and uses thereof
|
|
AU2002305914A1
(en)
|
2001-01-12 |
2002-10-21 |
Chiron Corporation |
Nucleic acid mucosal immunization
|
|
WO2003023026A1
(en)
|
2001-09-06 |
2003-03-20 |
Alphavax, Inc. |
Alphavirus replicon vector systems
|
|
WO2004055216A2
(en)
|
2002-12-13 |
2004-07-01 |
Fox Chase Cancer Center |
Replication of hepatitis c virus in non-hepatic epithelial and mouse hepatic cells
|
|
CA2539490A1
(en)
|
2003-09-18 |
2005-03-24 |
Genmab A/S |
Differentially expressed tumour-specific polypeptides for use in the diagnosis and treatment of cancer
|
|
WO2005107760A1
(en)
|
2004-04-30 |
2005-11-17 |
Irm Llc |
Compounds and compositions as inducers of keratinocyte differentiation
|
|
PT1751289E
(pt)
|
2004-05-18 |
2009-03-31 |
Alphavax Inc |
Vectores de alfavirais derivados da tc-83, partículas e métodos
|
|
TWI388344B
(zh)
|
2005-08-23 |
2013-03-11 |
Celsion Corp |
儲存奈米微粒調合物之方法
|
|
WO2007098267A2
(en)
|
2006-02-27 |
2007-08-30 |
The Board Of Regents Of The University Of Texas System |
Pseudoinfectious flavivirus and uses thereof
|
|
EP2468300B1
(en)
|
2006-09-26 |
2017-12-20 |
Infectious Disease Research Institute |
Vaccine composition containing synthetic adjuvant
|
|
WO2008124647A2
(en)
|
2007-04-04 |
2008-10-16 |
Infectious Disease Research Institute |
Immunogenic compositions comprising mycobacterium tuberculosis polypeptides and fusions thereof
|
|
US9446150B2
(en)
*
|
2007-10-09 |
2016-09-20 |
Washington University |
Particles for imaging
|
|
US9370558B2
(en)
|
2008-02-13 |
2016-06-21 |
President And Fellows Of Harvard College |
Controlled delivery of TLR agonists in structural polymeric devices
|
|
EP2401365B1
(en)
|
2009-02-24 |
2016-04-27 |
The Scripps Research Institute |
Reengineering mrna primary structure for enhanced protein production
|
|
CA2764374C
(en)
|
2009-06-05 |
2019-11-19 |
Infectious Disease Research Institute |
Synthetic glucopyranosyl lipid adjuvants
|
|
CN102811743B
(zh)
|
2009-12-11 |
2015-11-25 |
佰恩德治疗股份有限公司 |
冻干治疗颗粒的稳定制剂
|
|
US8722853B2
(en)
|
2010-06-10 |
2014-05-13 |
University Of Washington Through Its Center For Commercialization |
Methods and systems for adenovirus interaction with desmoglein 2 (DSG2)
|
|
US9555136B2
(en)
|
2010-06-21 |
2017-01-31 |
University Of Washington Through Its Center For Commercialization |
Coated magnetic nanoparticles
|
|
CA2804591C
(en)
|
2010-07-06 |
2019-01-22 |
Novartis Ag |
Cationic oil-in-water emulsions
|
|
PT3243526T
(pt)
|
2010-07-06 |
2020-03-04 |
Glaxosmithkline Biologicals Sa |
Distribuição de arn para despoletar múltiplas vias imunitárias
|
|
US9655845B2
(en)
|
2011-07-06 |
2017-05-23 |
Glaxosmithkline Biologicals, S.A. |
Oil-in-water emulsions that contain nucleic acids
|
|
US9101669B2
(en)
|
2012-01-31 |
2015-08-11 |
Postech Academy-Industry Foundation |
Self-assembed conjugate and use thereof
|
|
EP4299138A3
(en)
|
2012-08-03 |
2024-08-14 |
Access to Advanced Health Institute |
Compositions and methods for treating an active mycobacterium tuberculosis infection
|
|
US20160000886A1
(en)
|
2013-02-22 |
2016-01-07 |
President And Fellows Of Harvard College |
Nanostructured active therapeutic vehicles and uses thereof
|
|
US9775894B2
(en)
|
2013-07-09 |
2017-10-03 |
University Of Washington Through Its Center For Commercialization |
Methods and compositions for activation of innate immune responses through RIG-I like receptor signaling
|
|
RU2546249C2
(ru)
|
2013-08-07 |
2015-04-10 |
Силезиа Груп Пте. Лтд. |
Композиция для усиления экспрессии трансгена в эукариотических клетках и способ увеличения продукции целевого белка, кодируемого трансгеном
|
|
IL310015B2
(en)
|
2013-12-31 |
2026-02-01 |
Access To Advanced Health Inst |
Single vial formulation
|
|
HRP20220070T1
(hr)
|
2014-04-23 |
2022-04-01 |
Modernatx, Inc. |
Cjepiva nukleinske kiseline
|
|
SG11201705820UA
(en)
|
2015-01-16 |
2017-08-30 |
Nat Inst Advanced Ind Science & Tech |
Gene expression system using stealthy rna, and gene introduction/expression vector including said rna
|
|
AU2016251687C1
(en)
|
2015-04-22 |
2023-07-27 |
CureVac SE |
RNA containing composition for treatment of tumor diseases
|
|
CN106176599A
(zh)
|
2015-05-06 |
2016-12-07 |
江苏天士力帝益药业有限公司 |
一种卡巴他赛脂肪乳注射剂及其制备方法
|
|
US11364292B2
(en)
|
2015-07-21 |
2022-06-21 |
Modernatx, Inc. |
CHIKV RNA vaccines
|
|
CN106445676B
(zh)
*
|
2015-08-05 |
2019-10-22 |
杭州海康威视系统技术有限公司 |
一种分布式数据计算的任务分配方法和任务分配装置
|
|
EP3352785A1
(en)
*
|
2015-09-23 |
2018-08-01 |
Massachusetts Institute Of Technology |
Compositions and methods for modified dendrimer nanoparticle vaccine delivery
|
|
KR20180082457A
(ko)
|
2015-10-16 |
2018-07-18 |
마리누스 파마슈티컬스 인코포레이티드 |
나노입자들을 포함하는 주사용 뉴로스테로이드 제제들
|
|
MA46023A
(fr)
|
2015-10-22 |
2019-07-03 |
Modernatx Inc |
Vaccin contre le virus de la grippe à large spectre
|
|
EP3364949A4
(en)
|
2015-10-22 |
2019-07-31 |
ModernaTX, Inc. |
CANCER VACCINES
|
|
WO2017070624A1
(en)
|
2015-10-22 |
2017-04-27 |
Modernatx, Inc. |
Tropical disease vaccines
|
|
DK3386484T3
(da)
|
2015-12-10 |
2022-07-04 |
Modernatx Inc |
Sammensætninger og fremgangsmåder til afgivelse af terapeutiske midler
|
|
DE102017206254B4
(de)
|
2016-04-13 |
2024-07-11 |
Dialog Semiconductor (Uk) Limited |
DC-DC-Umwandlung für Mehrzellen-Batterien
|
|
JP7250520B2
(ja)
|
2016-04-13 |
2023-04-03 |
ヤンセン ファーマシューティカルズ,インコーポレーテッド |
組換えアルテリウイルスレプリコン系およびその使用
|
|
KR102483033B1
(ko)
|
2016-05-16 |
2022-12-30 |
액세스 투 어드밴스드 헬스 인스티튜트 |
페길화된 리포솜 및 이의 용도
|
|
RU2761870C2
(ru)
|
2016-05-16 |
2021-12-13 |
Инфекшес Дизис Рисёрч Инститьют |
Состав, содержащий агонист tlr, и способы применения
|
|
EP3458088A2
(en)
|
2016-05-21 |
2019-03-27 |
Infectious Disease Research Institute |
Compositions and methods for treating secondary tuberculosis and nontuberculous mycobacterium infections
|
|
EP3463300A1
(en)
|
2016-06-01 |
2019-04-10 |
Infectious Disease Research Institute |
Nanoalum particles containing a sizing agent
|
|
EP3468537A1
(en)
|
2016-06-14 |
2019-04-17 |
Modernatx, Inc. |
Stabilized formulations of lipid nanoparticles
|
|
WO2018022957A1
(en)
*
|
2016-07-29 |
2018-02-01 |
Tarveda Therapeutics, Inc. |
T cell binding conjugates and methods of use
|
|
KR20180025701A
(ko)
|
2016-09-01 |
2018-03-09 |
(주)아모레퍼시픽 |
특정 siRNA을 포함하는 멜라닌 증진용 조성물
|
|
WO2018053294A1
(en)
|
2016-09-16 |
2018-03-22 |
Infectious Disease Research Institute |
Vaccines comprising mycobacterium leprae polypeptides for the prevention, treatment, and diagnosis of leprosy
|
|
ES2993107T3
(en)
|
2016-10-17 |
2024-12-23 |
Janssen Pharmaceuticals Inc |
Recombinant virus replicon systems and uses thereof
|
|
WO2018081638A1
(en)
|
2016-10-27 |
2018-05-03 |
The Trustees Of The University Of Pennsylvania |
Nucleoside-modified rna for inducing an adaptive immune response
|
|
WO2018147710A1
(ko)
|
2017-02-13 |
2018-08-16 |
단디바이오사이언스 주식회사 |
이미다조퀴놀린계열 물질을 포함하는 나노에멀젼 및 이의 용도
|
|
AU2018285694B2
(en)
*
|
2017-06-15 |
2025-04-10 |
Access To Advanced Health Institute |
Nanostructured lipid carriers and stable emulsions and uses thereof
|
|
US12065649B2
(en)
|
2018-01-09 |
2024-08-20 |
Vanderbilt University |
Pattern recognition receptor agonist prodrugs and methods of use thereof
|
|
KR20200111729A
(ko)
|
2018-01-19 |
2020-09-29 |
얀센 파마슈티칼즈, 인코포레이티드 |
재조합 레플리콘 시스템을 이용한 면역 반응 유도 및 증진
|
|
AU2019215191B2
(en)
|
2018-02-02 |
2025-08-14 |
University Of Washington |
Compositions and methods for inducing tripartite motif-containing protein 16 (trim16) signaling
|
|
US20190382450A1
(en)
|
2018-06-18 |
2019-12-19 |
University Of Maryland, College Park |
Newcastle disease virus-based vectored vaccine
|
|
KR20210104835A
(ko)
|
2018-12-19 |
2021-08-25 |
누클레인, 엘엘씨 |
분자 진단을 위한 장치 및 방법
|
|
WO2020146690A1
(en)
|
2019-01-10 |
2020-07-16 |
Massachusetts Institute Of Technology |
Methods for in vitro evolution of rna replicons
|
|
US11406699B2
(en)
|
2019-03-22 |
2022-08-09 |
George Mason University |
Alphavirus and compositions, methods, and kits related thereto
|
|
BR112021023726A2
(pt)
|
2019-05-25 |
2022-02-15 |
Infectious Disease Res Inst |
Composição e método para secagem por pulverização de uma emulsão de vacina adjuvante
|
|
GB201908729D0
(en)
|
2019-06-18 |
2019-07-31 |
Imp College Innovations Ltd |
RNA construct
|
|
EP4004037A1
(en)
|
2019-07-26 |
2022-06-01 |
Vanderbilt University |
Human monoclonal antibodies to enterovirus d68
|
|
US11716044B2
(en)
*
|
2019-09-02 |
2023-08-01 |
Toshiba Mitsubishi-Electric Industrial Systems Corporation |
Power conversion device and electric motor drive system
|
|
US11679163B2
(en)
*
|
2019-09-20 |
2023-06-20 |
Hdt Bio Corp. |
Compositions and methods for delivery of RNA
|
|
WO2021194672A1
(en)
*
|
2020-03-23 |
2021-09-30 |
Hdt Bio Corp. |
Compositions and methods for delivery of rna
|
|
JP2022550454A
(ja)
|
2019-10-02 |
2022-12-01 |
ユニバーシティ オブ ワシントン |
B型肝炎ウイルス感染の治療のための組成物及び方法
|
|
WO2021072112A1
(en)
|
2019-10-09 |
2021-04-15 |
Hdt Bio Corp. |
Detection of desmoglein-2 in cancers of epithelial origin
|
|
AU2020367786A1
(en)
|
2019-10-14 |
2022-05-26 |
The Regents Of The University Of California |
Nano-enabled immunotherapy in cancer
|
|
KR102754152B1
(ko)
*
|
2019-10-18 |
2025-01-14 |
현대모비스 주식회사 |
사이드 에어백 장치
|
|
BR112022016054A2
(pt)
|
2020-02-14 |
2022-10-11 |
Altimmune Inc |
Composições imunogênicas para coronavírus e usos das mesmas
|
|
WO2021178416A1
(en)
|
2020-03-02 |
2021-09-10 |
Heat Biologics, Inc. |
Immune-mediated coronavirus treatments
|
|
US11478543B1
(en)
|
2020-03-06 |
2022-10-25 |
Thomas Jefferson University |
Coronavirus disease (COVID-19) vaccine
|
|
JP2023517644A
(ja)
|
2020-03-09 |
2023-04-26 |
アークトゥラス・セラピューティクス・インコーポレイテッド |
コロナウイルスワクチン組成物及び方法
|
|
TWI891771B
(zh)
|
2020-04-17 |
2025-08-01 |
美商Vlp醫療股份有限公司 |
冠狀病毒疫苗
|
|
WO2022051024A1
(en)
|
2020-09-04 |
2022-03-10 |
Infectious Disease Research Institute |
Genetically-adjuvanted rna vaccines
|
|
US20230310323A1
(en)
|
2020-09-04 |
2023-10-05 |
Access To Advanced Health Institute |
Co-lyophilized rna and nanostructured lipid carrier
|
|
JP2024501949A
(ja)
|
2020-12-23 |
2024-01-17 |
アクセス ツー アドバンスト ヘルス インスティチュート |
ソラネソールワクチンアジュバント及びその調製方法
|
|
WO2022217079A1
(en)
|
2021-04-08 |
2022-10-13 |
Georgia State University Research Foundation, Inc. |
Graphene oxide nanoparticles and methods of use for stimulating immune responses
|
|
IN202121031414A
(cg-RX-API-DMAC7.html)
|
2021-07-13 |
2023-01-13 |
|
|
|
IN202121038492A
(cg-RX-API-DMAC7.html)
|
2021-08-25 |
2023-03-03 |
|
|
|
AU2022358446A1
(en)
|
2021-09-22 |
2024-04-18 |
Hdt Bio Corp. |
Compositions and methods for enhanced protein production
|
|
WO2023049636A2
(en)
|
2021-09-22 |
2023-03-30 |
Hdt Bio Corp. |
Cancer therapy compositions and uses thereof
|
|
WO2023049363A1
(en)
|
2021-09-24 |
2023-03-30 |
Amgen Inc. |
Sotorasib and afatinib for treating cancer comprising a kras g12c mutation
|